Inclisiran is a subcutaneously administered synthetic small interfering RNA directed against proprotein convertase subtilisin–kexin type 9, leading to sustained low-density lipoprotein cholesterol ...
This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the ...
11/09/2023 Interim rule, correction. Federal Acquisition Regulation: Implementation of Federal Acquisition Supply Chain Security Act (FASCSA) Orders; Correction 10/05/2023 Interim rule. Federal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results